PBK and acute myeloid leukemia: TOPK is a modulator of CEBPA activity in FLT3-ITD mutated AML cells; therefore, inhibition of TOPK reduces phosphorylation of CEBPA p42, which then becomes available to bind E2F1 and suppresses the transcriptional activity of E2F1/MYC [46].